InnoCare Pharma Ltd. (INCPF)
1.85
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
InnoCare Pharma Gross Profit Margin (Quarterly) : 86.94% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.94% |
| March 31, 2026 | 83.74% |
| December 31, 2025 | 92.77% |
| September 30, 2025 | 80.83% |
| June 30, 2025 | 81.06% |
| March 31, 2025 | 83.80% |
| December 31, 2024 | 79.06% |
| September 30, 2024 | 86.17% |
| June 30, 2024 | 76.04% |
| March 31, 2024 | 70.25% |
| December 31, 2023 | 74.30% |
| September 30, 2023 | 69.37% |
| June 30, 2023 | 71.20% |
| March 31, 2023 | 66.15% |
| December 31, 2022 | 75.79% |
| September 30, 2022 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00% |
| March 31, 2022 | 75.95% |
| December 31, 2021 | 55.04% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.63% |
| Return on Assets | 8.90% |
| Return on Invested Capital | 10.14% |
| Profit Margin (Quarterly) | 22.55% |
| Operating Margin (Quarterly) | 12.18% |
| Return on Net Operating Assets | 53.14% |